Top 50 Life Science Startup Investors in Spain (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
9 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $170k–$15M |
|
BeAble Capital
VC Fund
|
7 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
Bullnet Capital
VC Fund
|
7 | Spain, United States, Mexico | Seed, Series A | Software, Manufacturing, Information Technology | $567k–$11M |
|
Capital Cell
VC Fund
|
7 | Spain, France, United States | Equity Crowdfunding, Seed, Series A | Health Care, Biotechnology, Medical | $137k–$21M |
|
Invivo Capital Partners
VC Fund
|
6 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$70M |
|
Asabys Partners
VC Fund
|
5 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.3M–$135M |
|
Inveready
VC Fund
|
4 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $439k–$14M |
|
ENISA
VC Fund
|
4 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$1.6M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
4 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $266k–$16M |
|
Nara Capital
VC Fund
|
4 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
Alta Life Sciences
VC Fund
|
3 | Spain, United States | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Therapeutics | $3M–$87M |
|
Ysios Capital
VC Fund
|
3 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
Inveniam
VC Fund
|
2 | Spain | Seed, Grant | Biopharma, Health Care, Life Science | $568k–$1.1M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Grow Venture Partners
VC Fund
|
2 | Spain, Sweden | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Biotechnology | $106k–$9.5M |
|
European Investment Bank
VC Fund
|
2 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$726M |
|
Speedinvest
VC Fund
|
2 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $713k–$33M |
|
Talis Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Information Technology, E-Commerce | $1M–$30M |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology | $3.4M–$7.3M |
|
CDTI
VC Fund
|
2 | Spain, United States, Mexico | Venture - Series Unknown, Seed | Software, Information Technology, Health Care | $314k–$5.4M |
|
Clave Capital
VC Fund
|
2 | Spain, Chile, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Software | $462k–$21M |
|
Demium Capital
VC Fund
|
2 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $110k–$3.1M |
|
Fund+
VC Fund
|
2 | Belgium, United States, Spain | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$401M |
|
BStartup - Banc Sabadell
VC Fund
|
2 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.3M |
|
Amadeus Capital Partners
VC Fund
|
2 | United Kingdom, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $900k–$60M |
|
Criteria Venture Tech
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
Charme Capital Partners
VC Fund
|
2 | Spain, Italy, United States | Private Equity, Series A | Health Care, Medical, Medical Device | $5.5M–$20M |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Switzerland | Seed, Series A | Artificial Intelligence, FinTech, Software | $375k–$100M |
|
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund
|
2 | Spain | Series A, Grant, Pre-Seed | Semiconductor, Life Science, Manufacturing | $390k–$1.4M |
|
Xesgalicia
VC Fund
|
2 | Spain, Portugal | Seed, Venture - Series Unknown | Software, Biotechnology, B2B | $304k–$5.9M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $274k–$115M |
|
Criteria Bio Ventures
VC Fund
|
2 | United Kingdom, Spain | Seed, Pre-Seed, Series A | Biotechnology, Life Science, Medical | $3.5M–$83M |
|
Banc Sabadell and the Institut Català de Finances (ICF)
VC Fund
|
1 | Spain, Switzerland | Debt Financing, Seed, Pre-Seed | Wellness, Health Care, Medical Device | $186k–$425M |
|
Clave Mayor
VC Fund
|
1 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
Gilde Healthcare
VC Fund
|
1 | United States, The Netherlands, Germany | Series B, Series C, Series A | Health Care, Biotechnology, Medical | $9.5M–$135M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Veg Capital
VC Fund
|
1 | United Kingdom, Brazil, Sweden | Seed, Equity Crowdfunding, Pre-Seed | Food and Beverage, Organic Food, Food Processing | $212k–$10M |
|
Alma Mundi Ventures
VC Fund
|
1 | Spain, United States, United Kingdom | Series A, Seed | Software, Insurance, InsurTech | |
|
Debiopharm Innovation Fund
VC Fund
|
1 | Switzerland, United States, France | Series A, Seed, Pre-Seed | Health Care, Biotechnology, Software | $943k–$25M |
|
Milad Alucozai
Angel
|
1 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | |
|
Fides Capital
VC Fund
|
1 | Spain | Seed, Pre-Seed, Series A | Software, Automotive, Telecommunications | |
|
Ryan Bethencourt
Angel
|
1 | United States, Chile, India | Pre-Seed, Seed, Angel | Biotechnology, Food Processing, Food and Beverage | |
|
BAGi
VC Fund
|
1 | Spain, Norway, Switzerland | Seed, Angel | Internet, Health Care, Information Technology | |
|
Alantra
VC Fund
|
1 | Spain, France, Sweden | Private Equity, Debt Financing, Series B | Financial Services, Manufacturing, Information Technology | |
|
SeedBlink
VC Fund
|
1 | Romania, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | |
|
Ship2B Ventures
VC Fund
|
1 | Spain, Germany, United Kingdom | Seed, Series A | Health Care, Biotechnology, Agriculture | |
|
Arnaldo Marziali
Angel
|
1 | Spain | Pre-Seed | Big Data, Software, Life Science | |
|
General Inception
VC Fund
|
1 | United States, Spain, France | Seed, Pre-Seed | Biotechnology, Life Science, Genetics | |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
Pontifax
VC Fund
|
1 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$128M |
| Access all 160 investors in Spain Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 217
- Round size: Seed $576k–$5.8M; Grant $170k–$15M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Phoenix Foods — Phoenix Foods uses insect farming to solve the problems of organic waste management and the requirement for high-quality proteins in animal feed.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 69
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$274k
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Molecular Gate — Transformative Anti-Counterfeiting Technology. Multifunctional Level 1 Anti-Counterfeit Solutions: See-through Polargram and Reflective Polargram
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 66
- Round size: Seed $1M–$3.2M; Series A $567k–$11M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — Impetux is a worldwide key manufacturer and supplier of turnkey optical tweezers systems designed for mechanobiology studies in living cells and 3D tissues.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed, Series A
- Geography: Spain, France, United States
Investor stats
- Total investments: 52
- Round size: Seed $384k–$1.9M; Series A $1.1M–$21M; Equity Crowdfunding $137k–$1.5M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 31
- Round size: Seed $1.6M–$13M; Series A $2.2M–$70M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- Pulmobiotics — Pulmobiotic is a spin off company from the Centre for Genomic Regulation (Barcelona - Spain) founded by experienced entrepreneurs and funded by invivo Ventures. Pulmobiotics will use its technology to discover and develop novel treatments and vaccines for respiratory diseases.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Fostering breakthrough innovation in healthcareAsabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. PORTFOLIO TEAM Impact We want to push the boundaries of science and medicine improving patient's life Disruptive We look for highly innovative and transformative technologies Hands-on We consider ourselves partners and collaborators to our portfolio
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.3M–$13M; Series A $7M–$57M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 203
- Round size: Seed $439k–$5.8M; Series A $1.6M–$14M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Voztelecom — VozTelecom develops software to enable Voice over Internet Protocol (VoIP) services over Internet. The company's products include miVoz.net, personal IP telephony service; intraVoz.net, local area network (LAN) IP telephony service with enhanced features; extraVoz.net, a hosted IP telephony service; vozConference.net, a hosted Web-conferenceservice with enhanced collaboration features; and wifiVoz.net, application that enables the usage of VozTelecom service through any wireless terminal. Voz has strategic alliances with Interxion, Cisco Systems, Iptel.org, SIP Phone, Jasomi Networks, Midworld Networks, and Endercom. The company was founded in 2003 and is headquartered in Cerdanyola, Spain.
- Inventia Kinetics — Inventia Kinetics specializes in the design, analysis, and manufacture of equipment and assembly tools for electronics sector.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 231
- Round size: Seed $67k–$1.6M; Pre-Seed $165k–$1.2M; Debt Financing $66k–$489k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Biotasmart — Plataforma que convierte datos de la microbiota intestinal en recomendaciones nutricionales personalizadas.
- DARWIN Biomed — Biomedical Engineering
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 52
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Zoundream — The Future of Infant Care
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$33M; Series B $13M–$87M; Venture - Series Unknown $3.3M–$13M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 81
- Round size: Series A $3.8M–$62M; Series B $20M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
Strategic consulting for meaningful innovations in health, sustainability and deep tech.
Show more...Investment focus
- Industry: Biopharma, Health Care, Life Science
- Stage:Seed, Grant
- Geography: Spain
Investor stats
- Total investments: 4
- Round size: Seed $568k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
- NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- X1 Wind — X1 Wind is a disruptive innovative floating wind platform with the potential to make a step change in offshore wind.
- NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 520
- Round size: Post-IPO Debt $18M–$726M; Debt Financing $16M–$352M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Ukrposhta — Ukrposhta sends and receives shipments from all over the world, as well as orders mail products sent to the most distant corners.
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 603
- Round size: Seed $1M–$8M; Pre-Seed $713k–$3.8M; Series A $4.1M–$33M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- Facility — Flexkeeping is a Hotel Operations Platform designed to help teams automate and collaborate like never before.
- Polaron — Material Design. Supercharged with AI.
We back founders who see the future differently.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 82
- Round size: Seed $1M–$15M; Series A $3M–$22M; Series B $10M–$30M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- AKUA — AKUA is a subscription data service delivering actionable, real-time, and secure business intelligence directly to cargo owners. Their flexible IoT platform provides persistent environmental monitoring and tracking solutions for intermodal cargo containers with no new equipment to buy or manage. AKUA IoT gateway devices, sensors, and devicelogistics are included in the subscription, and any existing IoT sensors can also be integrated into the system. AKUA combines the industry's most advanced tracking devices, tamper-resistant and tamper-evident multi-layer security, and in-transit analytics into a seamless cloud-based solution.
- Zyper — Zyper is a machine learning-led community marketing software that helps brands connect with their fans, and fans connect with each other. The platform wants to re-create social networks for brands by connecting them to their top fans to drive engagement, insights, and sales. It enables brands to identify and engage with their top 1% of fans andbuild a community of active brand advocates.Zyper was founded in 2017 and is headquartered in San Francisco, California, United States.
- Pass the Keys — Pass the Keys is an airbnb management company offers an expert Airbnb and short let management service. They create opportunities in every corner of the world, for their hosts, their guests and their people.The UK’s largest professional co-host they list your property on platforms like Airbnb, so you don’t have to. Offering a fully-managedservice, Pass the Keys even finds, manages, and cleans up after your guests. With HQ in London and further satellite offices in all of their cities in the UK, they use tech to increase the money landlords are getting back from their property and manage those properties efficiently and effectively. What this means if you’re a landlord is more money and less work.
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Seed $3.4M–$7.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 36
- Round size: Seed $314k–$2.6M; Venture - Series Unknown $765k–$5.4M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 45
- Round size: Seed $462k–$5.5M; Series A $3.2M–$21M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 85
- Round size: Seed $113k–$3.1M; Pre-Seed $110k–$574k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- Aino — AI-powered spatial analytics platform for architecture, urban planning and development teams. Site analysis, GIS-free mapping and location intelligence. 400+ cities covered.
- Orbital Paradigm — Orbital Paradigm builds reusable vehicles that carry cargo to space and bring it back. Dedicated missions, any orbit, on your schedule. Based in Madrid.
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 32
- Round size: Series A $11M–$46M; Series B $22M–$125M; Series C $11M–$401M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 84
- Round size: Seed $110k–$2.3M; Pre-Seed $219k–$900k
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 243
- Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$60M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Unifyr — IDC MarketScape Leader 2025. AI-native PRM platform for partner onboarding, enablement, deal registration, and through-channel marketing.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 158
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Private Equity, Series A
- Geography: Spain, Italy, United States
Investor stats
- Total investments: 7
- Round size: Series A $5.5M–$20M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
- UNIVERSAE — UNIVERSAE offers vocational training services.
- Prism Healthcare — Transforming LivesA leading integrated solutions provider dedicated to transforming lives in the paediatric, home, and long-term care sectors. About Prism Healthcare Group Transforming Lives When health or mobility declines, the...
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Artificial Intelligence, FinTech, Software
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $375k–$9.3M; Series A $1.3M–$100M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Algorized — Algorized develops advanced technologies for human presence detection using UWB Radar.
- Ratio — A new way to finance subscription companies without dilution offering flexibility to help you thrive and compete. Put your recurring revenue to work.
- Scout AI — Scout AI is building the robotic foundation model for defense.
CDTI
Show more...Investment focus
- Industry: Semiconductor, Life Science, Manufacturing
- Stage:Series A, Grant, Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 11
- Round size: Series A $390k–$1.4M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Basquevolt — Basquevolt is a leader in solid state battery technology.
- FYLA — FYLA designs ultrafast fiber lasers, combining precision engineering and quality. Discover supercontinuum and femtosecond laser solutions.
- A4CELL — A4CELL is a company that develops SPAchip (suspended planar-array chips) that help monitor living single cells. They offer SPAchips, as well as the CytoCHECK SPAchip and the CytoCHECK SPAchip. The company's goal is to increase the accuracy and quality of cell study data in order to better understand disease behavior.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, B2B
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Portugal
Investor stats
- Total investments: 34
- Round size: Seed $304k–$5.9M; Venture - Series Unknown $904k–$5.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — PROFESSIONAL TEAM User can utilize his smartphone to pay for a wide range of services or any CONSULTATION User can utilize his smartphone to pay for a wide range of services or any TREATMENT User can utilize his smartphone to pay for a wide range of services or any First-in-class NCEs addressed to modulate challenging
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $1.3M–$9.5M; Pre-Seed $274k–$2M; Series A $717k–$115M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Thred — Thred is the first B2B Intent platform designed for AI. Act on accounts researching in ChatGPT, Gemini, and Claude.
Supporting life-changing therapies through long-term strategic partnerships
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Spain
Investor stats
- Total investments: 7
- Round size: Pre-Seed $3.5M–$3.5M; Series A $29M–$83M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
- Adaptam Therapeutics — Pioneering cancer immunotherapies targeting the immunosuppressive myeloid tumor microenvironment for the treatment of solid tumors.
- Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Banc Sabadell and the Institut Català de Finances (ICF)
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Debt Financing, Seed, Pre-Seed
- Geography: Spain, Switzerland
Investor stats
- Total investments: 6
- Round size: Debt Financing $186k–$425M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
- NH Hoteles — NH Hotel Group is a consolidated travel and leisure hotel operator. It is one of the top 25 hotel chains in the world and one of the main ones in Europe, currently operating close to 400 hotels with almost 60,000 rooms in 31 countries in Europe, America, and Africa.
- Impala Terminals — Impala Terminals Group facilitates the global trade of commodities by offering producers and consumers reliable and efficient access to international markets.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 131
- Round size: Series A $9.5M–$63M; Series B $15M–$135M; Series C $21M–$75M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $786M in 2023
Portfolio highlights
- Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
- GT Medical Technologies — GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 95
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more...Investment focus
- Industry: Food and Beverage, Organic Food, Food Processing
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United Kingdom, Brazil, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $212k–$10M; Pre-Seed $600k–$2M; Equity Crowdfunding $286k–$5.1M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Nutropy — Nutropy produces real milk ingredients, identical to those produced by cows, to develop premium cheese alternatives that taste just as good as cow’s cheese but are more sustainable, healthier and better for the animals. No animals involved, full cheese experience.
- Purezza — The best vegan pizza restaurant and plant-based Italian menu. Purezza has restaurants in Brighton, London (Camden) and Manchester.
- SHICKEN Foods — Plant-based chicken manufacturer
We back bold and purpose-driven founders.
Show more...Investment focus
- Industry: Software, Insurance, InsurTech
- Stage:Series A, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 108
- Lead/follow: no public data
Portfolio highlights
- LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
- Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Pre-Seed
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 37
- Round size: Seed $943k–$6M; Series A $3.5M–$25M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- Neuroute —
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
- VeriSIM Life — Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 54
- Lead/follow: no public data
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more...Investment focus
- Industry: Software, Automotive, Telecommunications
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more...Investment focus
- Industry: Biotechnology, Food Processing, Food and Beverage
- Stage:Pre-Seed, Seed, Angel
- Geography: United States, Chile, India
Investor stats
- Total investments: 16
- Lead/follow: no public data
Portfolio highlights
- Evo Foods — EVO foods is creating India’s first 100% plant based liquid egg
- WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
- Arcturus BioCloud — Arcturus delivers granular insights, climate metrics and sustainability risks on the drivers of climate and ESG profiles for investment holdings via a climate and Sustainability Intelligence SaaS.
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more...Investment focus
- Industry: Internet, Health Care, Information Technology
- Stage:Seed, Angel
- Geography: Spain, Norway, Switzerland
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
Alantra is an international financial services firm with over 500 professionals across EMEA, the Americas, and Asia.
Show more...Investment focus
- Industry: Financial Services, Manufacturing, Information Technology
- Stage:Private Equity, Debt Financing, Series B
- Geography: Spain, France, Sweden
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
- SunRoof — Roof of the future
- Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.
All-in-one solution for fundraising, managing and trading equity. Explore promising tech startups and flexible funding opportunities with SeedBlink.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Romania, United States, United Kingdom
Investor stats
- Total investments: 103
- Lead/follow: no public data
Portfolio highlights
- Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
- Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
- dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.
Ship2B Ventures is a venture capital firm that invests in impact startups.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Agriculture
- Stage:Seed, Series A
- Geography: Spain, Germany, United Kingdom
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
- Nido — Heating & cooling accounts for nearly half of all energy consumption and 40% of energy-related carbon dioxide emissions. In the EU 65M+ boilers are over their useful life and 95% of them use fossil fuels and these need urgent change.At Nido, we are streamlining heat pump installation in the residential sector, enabling users to transition toclean heating & cooling faster with affordable pricing. We also support installers get the best out of their time by removing time consuming tasks and allowing them to focus on their preferred task - home installations!
- Ocean Ecostructures — We convert maritime infrastructures into 'nature positive' spaces through our multi-technological solution.
Arnaldo Marziali
Show more...Investment focus
- Industry: Big Data, Software, Life Science
- Stage:Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Genetics
- Stage:Seed, Pre-Seed
- Geography: United States, Spain, France
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Biocellis — Biocellis develops ultra-sensitive, bioluminescence-based diagnostics for next-generation immunoassays. Scalable, fast, and point-of-care ready.
- Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
- Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 288
- Lead/follow: no public data
Portfolio highlights
- DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
- AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
- Excelsior Sciences — Rebuilding the World, From the Bottom Up
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 113
- Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
- Graviton Bioscience — Curing Disease through Restored Homeostasis
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Life Science Investor funding in Spain at a glance
Stats across 139 deals from 160 investors.
Access all 160 investors in Spain Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 160 investors investing in Spain Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!